This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.94% per year. These returns cover a period from January 1, 1988 through July 6, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
insurance: Archive
American International to Report Q3 Earnings: Key Estimates to Note
by Zacks Equity Research
AIG's Q3 results are likely to reflect solid investment and underwriting gains, but face pressure from catastrophe losses and higher expenses.
earnings finance insurance
4 Insurance Stocks Set to Pull Off a Beat This Earnings Season
by Sushmita Sarker
Solid retention, renewals, prudent pricing, exposure growth, and improved digitalization are expected to help PRI, CNA, AIZ, and UNM outperform third-quarter estimates.
insurance
Root Gears Up to Report Q3 Earnings: Here's What to Expect
by Zacks Equity Research
Root's Q3 results may show stronger premiums and investment income, though higher expenses could weigh on margins.
insurance
Premium Performers or Policy Flops? 3 Insurers Face Q3 Earnings Test
by Kaibalya Pravo Dey
Aflac, AIG and Assurant gear up for Q3 results as strong pricing, sales and digital gains boost the insurance sector's outlook.
earnings finance insurance
5 Momentum Stocks to Buy for November After an Impressive October
by Nalak Das
After a stellar October for Wall Street, five momentum plays, TRV, NEM, FIX, GLW and TEL, stand out as strong buys heading into November.
communications construction gold insurance tech-stocks
Company News for Nov 3, 2025
by Zacks Equity Research
Companies In The News Are: AON, CVX, GWW, MGA.
auto-tires-trucks industrial-products insurance oil-energy
AMERISAFE Q3 Earnings Met Estimates, New Business Growth Aids
by Zacks Equity Research
AMSF's Q3 EPS meet estimates as strong policy retention and new business growth offset weaker investment income. Management announced a special cash dividend of $1.00 per share.
earnings insurance
Aon Q3 Earnings Beat Estimates on Reinsurance Solutions Strength
by Zacks Equity Research
AON's Q3 beat estimates as robust Reinsurance Solutions performance and steady client retention fueled solid revenue growth.
earnings finance insurance
Reinsurance Group Q3 Earnings Top Estimates on Solid Investment Income
by Zacks Equity Research
RGA's Q3 results reflect solid performance in the Asia/Pacific, U.S. and Latin America, and Canada segments, offset by lower premiums.
insurance
Prescription for Beats: 3 Healthcare Stocks Set to Outperform in Q3
by Kaibalya Pravo Dey
Humana, Cencora and Globus Medical are poised to outshine in the September quarter, driven by strong demand, innovation and volume growth.
biotechnology earnings insurance medical medical-devices pharmaceuticals